Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 5.23
+0.09 (1.75%)
May 7, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 9.44 billion as of May 7, 2026. Its market cap has increased by 30.42% in one year.
Market Cap
9.44B
Enterprise Value
9.53B
Revenue
1.04B
Ranking
n/a
PE Ratio
31.56
Stock Price
5.23
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 9.44B, a decrease of -20.31%. That is a compound annual growth rate of -5.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 9.44B | 5.23% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 12.09B |
| CARsgen Therapeutics Holdings | 11.36B |
| HBM Holdings | 10.92B |
| Alphamab Oncology | 9.83B |
| Shanghai Haohai Biological Technology | 9.41B |
| Shanghai Bao Pharmaceuticals | 8.48B |
| Abbisko Cayman | 8.42B |
| CK Life Sciences Int'l., (Holdings) | 7.11B |